IBD is a group of chronic inflammatory bowel disorders, including Crohn's disease and ulcerative colitis, that can be managed with lifestyle changes, medications, and in some cases, surgery.

The global IBS and IBD therapeutics market is set to grow from $33.3 billion in 2025 to $52.6 billion by 2030, at a 9.6% CAGR ...

A major cause of inflammatory bowel disease (IBD) has been discovered which could be treated with existing drugs. The breakthrough was described as a "massive step forwards" by researchers. IBD is the ...

Inflammatory bowel disease (IBD) describes a group of conditions—the two main forms being Crohn's disease and ulcerative colitis—that cause inflammation of the gastrointestinal tract and ...

More than 6 million people globally have inflammatory bowel disease (IBD). Diet plays a role in both possibly increasing a person’s risk for developing IBD, as well as helping to alleviate symptoms.